Business Context and Reporting Period
This Form 6-K filing serves as the Notice of Annual General Meeting and Proxy Statement for Amdocs Limited, a foreign private issuer. The meeting is scheduled for January 30, 2026, to address matters related to the fiscal year ended September 30, 2025. The record date for shareholders entitled to vote is December 2, 2025. As of this date, there were 107,949,539 ordinary shares outstanding.
Key Financial Metrics and Capital Allocation
The filing focuses on capital allocation strategies rather than detailed operational financial statements, which are referenced as being contained in the Annual Report on Form 20-F.
- Dividend Program: The Board proposes increasing the quarterly cash dividend rate from $0.527 to $0.569 per share, subject to shareholder approval.
- Share Repurchases: The Company repurchased approximately $551.3 million of its ordinary shares during the fiscal year ended September 30, 2025. Repurchase totals were $563.1 million in fiscal 2024 and $489.5 million in fiscal 2023.
- Equity Compensation: As of December 2, 2025, there were 1,520,394 shares subject to outstanding options and restricted stock units with a weighted average exercise price of $66.96. Approximately 4,993,282 shares remain available for future issuance under equity plans.
- Audit Fees: Total fees billed to Amdocs by Ernst & Young LLP for fiscal 2025 were $5.6 million ($3.3 million for audit, $1.2 million for audit-related, and $1.1 million for tax services).
Material Changes and Proposals
Shareholders are asked to vote on five specific proposals representing material changes to corporate governance and capital structure:
- Election of Directors: Election of 10 directors, including two (Robert A. Minicucci and Rafael de la Vega) who received waivers to serve past the mandatory retirement age of 73.
- ESPP Amendment: Approval to increase the number of ordinary shares reserved for the 2023 Employee Share Purchase Plan by 2,200,000 shares, raising the total reserve to 4,600,000 shares.
- Dividend Increase: Approval to raise the quarterly dividend rate to $0.569 per share, effective beginning in April 2026 if approved.
- Financial Statements: Approval of the Consolidated Financial Statements for the fiscal year ended September 30, 2025.
- Auditor Ratification: Ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal 2026.
Outlook, Risks, and Management Commentary
Capital Return Policy: Management states a long-term guideline to return a majority of free cash flow to shareholders through dividends and share repurchases, subject to financial performance, liquidity, and potential M&A activity.
Compensation Philosophy: The Company emphasizes aligning executive compensation with shareholder returns, targeting 50-70% of executive management compensation to be performance-contingent. No minimum guaranteed vesting for performance-based equity awards or guaranteed performance bonuses are provided.
Risk Management: The Board oversees risk management efforts related to strategic and business risks, while the Audit Committee specifically oversees enterprise risk management policies regarding operational and financial risks.
Unusual Items: The filing notes that two directors were granted one-year waivers to continue serving past the age of 73 due to their exceptional industry experience and value to the Board.
Investor Verification Checklist
- Verify the exact terms of the proposed dividend increase ($0.569/share) and the start date (April 2026) in the final proxy materials.
- Review the full Consolidated Financial Statements in the Form 20-F to confirm revenue, profit, and cash flow figures not detailed in this proxy.
- Confirm the impact of the 2,200,000 share increase to the ESPP on potential dilution relative to the current share count.
- Check the voting record for the two directors (Minicucci and de la Vega) who received age waivers to ensure alignment with shareholder expectations on governance.
- Monitor the Company's free cash flow generation to assess the sustainability of the proposed capital return policy.